The Cooper Companies, Inc. (0I3I.L)
| Previous close | 106.12 |
| Open | 106.81 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 105.30 - 106.81 |
| 52-week range | 75.88 - 106.81 |
| Volume | |
| Avg. volume | 934 |
| Market cap | 5.232B |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | 0.06 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
CooperCompanies Recognized as a Best Workplace for Innovators
Leading global medical device company recognized for culture that drives innovation for customers and patientsSAN RAMON, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) announced today that the company has been recognized as a Best Workplace for Innovators by Fast Company—a leading business media brand with an editorial focus on innovation—for creating a culture of employee development and belonging that inspires innovation and the development of new products and advocac
- Business Wire
CooperSurgical Launches Paragard® Intrauterine Copper Contraceptive with New Single-Hand Inserter
TRUMBULL, Conn., September 03, 2024--CooperSurgical, a global leader in women’s healthcare, today announced the launch of a new inserter designed for single-hand placement of Paragard®.
- GlobeNewswire
CooperCompanies Announces Third Quarter 2024 Results
SAN RAMON, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2024. Revenue increased 8% year-over-year to $1,002.8 million. CooperVision (CVI) revenue up 7% to $675.6 million, and CooperSurgical (CSI) revenue up 9% to $327.2 million.GAAP diluted earnings per share (EPS) of $0.52, up $0.09 or 22% from last year's third quarter.Non-GAAP diluted EPS of $0.96,
